Linked page lives on the broker site, not on OpenAcquisitions.
Key points
•Company has 25+ years of proprietary intellectual property in topoisomerase and DNA repair enzyme research for anti-cancer and antibiotic drug discovery.
•Products have 3,000+ literature citations validating the portfolio.
•Operates with global distribution through established channels.
•Owns a wholly owned, mortgage-free wet lab facility.
Business description
Niche life sciences company with proprietary IP covering the full spectrum of human topoisomerases and DNA repair enzymes, three distinct revenue streams, a debt-free owned lab facility, and over 3,000 literature citations across more than twenty years of operations.
